Mary C. Beckerle is an American cell biologist who studies cancer at the Huntsman Cancer Institute at the University of Utah School of Medicine. At Huntsman Cancer Institute, she serves as the CEO and also as Associate Vice President for Cancer Affairs at the University of Utah. Beckerle's research helped to define a novel molecular pathway for cell motility, and more recently, she has begun research into Ewing’s sarcoma, a pediatric bone cancer. Beckerle's lab made a ground breaking discovery in regards to Ewing's Sarcoma in relation to the EWS/FLI protein.[1] Her lab discovered EWS/FLI to disrupt the internal cellular skeleton, which decreases the ability of cells to adhere to their proper environment. This can help explain the metastasis of tumors in patients with Ewing's sarcoma.
- ^ Neufield, Erica. “Huntsman Cancer Institute Awarded Grant for Children's Cancer Research” CureSearch for Children’s Cancer. "Huntsman Cancer Institute Investigator Awarded Grant for Children's Cancer Research: CureSearch". Archived from the original on 2014-12-24. Retrieved 2014-11-26.